tbuckley/cabot-search huggingface dataset:
Klinische Wochenschrift, Berlin
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Preliminary Pages
Authors: Edgar Heim
Journal: Psychotherapy and Psychosomatics (2010)

Other Types| May 26 2010 Preliminary Pages Subject Area: Psychiatry and Psychology Edgar Heim Edgar Heim Search for other works by this author on: This Site PubMed Google Scholar Psychother Psychosom (2010) 79 (Suppl. 1): I–XII. https://doi.org/10.1159/000288803 Article history Published Online: May 26 2010 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Edgar Heim; Preliminary Pages. Psychother Psychosom 1 May 2010; 79 (Suppl. 1): I–XII. https://doi.org/10.1159/000288803 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsPsychotherapy and Psychosomatics Search Advanced Search Article PDF first page preview Close Modal This content is only available via PDF. 2010Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.
THE FAR FLYING FLY
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
ABDOMINOTHORACIC WOUND WITH EVISCERATION OF SPLENIC FLEXURE
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Münchener Medizinische Wochenschrift
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Radioactive Vitamin B12 After Partial Gastrectomy
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 1670: A hidden markov modeling approach for identifying tumor subclones in next-generation sequencing studies
Authors: Bin Zhu, Hyoyoung Choo-Wosoba, Paul Albert
Journal: Cancer Research (2019)

Abstract Allele-specific copy number alteration (ASCNA) analysis is for identifying copy number abnormalities in tumor cells. Unlike normal cells, tumor cells are heterogeneous with a combination of dominant and minor subclones with distinct copy number profiles. Estimating the clonal proportion and identifying main and subclone genotypes across the genome is important for understanding tumor progression. Several ASCNA tools have recently been developed, but they have been limited to the identification of subclone regions, and not the genotype of the subclones. In this paper, we propose subHMM, a hidden Markov model-based approach that estimates both subclone region as well as region-specific subclone genotype and clonal proportion. We specify a hidden state variable representing the conglomeration of clonal genotypes and subclone status. We propose a two-step algorithm for parameter estimation, where in the first step, a standard hidden Markov model with this conglomerated state space is fit. Then, in the second step, region-specific estimates of the clonal proportions are obtained by maximizing region-specific pseudo-likelihoods. We apply subHMM to a renal cell carcinoma dataset from The Cancer Genome Atlas. In addition, we conduct simulation studies that show the good performance of the proposed approach. Citation Format: Bin Zhu, Hyoyoung Choo-Wosoba, Paul Albert. A hidden markov modeling approach for identifying tumor subclones in next-generation sequencing studies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1670.
Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast
Authors: G. Adjorlolo-Johnson
Journal: JAMA (1994)

<h3>Objective.</h3> —To compare mother-to-child transmission of human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2, respectively) and to assess the impact of maternal HIV-1 and HIV-2 infections on child survival. <h3>Design.</h3> —Prospective cohort study. <h3>Setting.</h3> —Maternal and child health center in a lower socioeconomic class district of Abidjan, Ivory Coast. <h3>Participants.</h3> —A total of 18 099 women delivering between 1990 and 1992 were tested for HIV-1 and HIV-2 antibodies. A cohort of 613 pregnant women and their infants was followed prospectively (138 women reactive to HIV-1,132 reactive to HIV-2, 69 reactive to both viruses, and 274 HIV-seronegative). Main Outcome Measures.—Rates of perinatal transmission for HIV-1, HIV-2, and both viruses, determined from results of serological and polymerase chain reaction tests on children; survival of infants born to HIV-1—positive, HIV-2—positive, dually reactive, and HIV-seronegative women. <h3>Results.</h3> —Of the 18 099 women tested, 9.4% were reactive to HIV-1 alone, 1.6% to HIV-2 alone, and 1.0% to both viruses. The rate of perinatal transmission of HIV-1 was 24.7% (95% confidence interval [CI], 15.8% to 33.7%), compared with 1.2% (95% CI, 0.0% to 3.5%) for HIV-2 (relative risk, 21.3; 95% CI, 2.9 to 154.3). Overall, 19.0% (95% CI, 9.0% to 29.0%) of infants of dually reactive women became infected; of the 11 children concerned, 10 were infected with HIV-1 and one with HIV-1 and HIV-2. Infants of HIV-seropositive mothers had a reduced survival; mortality rates were 15.1, 13.0, 6.5, and 3.4 deaths per 100 child-years, respectively, for children of HIV-1—positive, dually reactive, HIV-2—positive, and HIV-seronegative women. <h3>Conclusions.</h3> —The rate of perinatal transmission of HIV-2 (1.2%) was much lower than the rate of perinatal transmission of HIV-1 (24.7%), and this was associated with more favorable survival for infants of HIV-2—infected mothers. Dually reactive women could transmit both viruses, although transmission usually involved HIV-1 only. Public health guidelines should incorporate advice that perinatal transmission of HIV-2 is rare. (<i>JAMA</i>. 1994;272:462-466)
Abstract 166: Reappraisal of Coronary Abnormalities Using Systemic Focused Coronary Echocardiographic Imaging in Kawasaki Disease
Authors: Kai-Sheng Hsieh, Chu-Chuan Lin, Huang-Wei Wu, Yu-Ci Hong
Journal: Circulation (2015)

Background: Coronary artery abnormalities (CAA) is an important complication in children with Kawasaki disease (KD). The incidence of CAA used to be around 5-10% after acute phase of KD. So far, there had been scanty information about the systemic approach to examine the status of coronary in children with KD. We thus developed a systemic focused coronary echocardiographic imaging (SFCEI) in Kawasaki disease. Methods: Between July 2013 and June 2014, a total of 35 patients with acute phase Kawasaki disease was enrolled in this study. Echocardiography of 100 normal pediatric patients was used for control. In this study, we employed the Siemens ACUSON SC2000 echocardiography system with 8V3 transducer (3-8MHz) for examination. All the patients was examined at diagnosis, 1 week, 2 weeks and repeating at 6-8 weeks after the onset of illness. Assessment of right coronary (proximal and distal portions), left main (middle portion), left anterior descending (proximal and distal portions) and circumflex arteries(proximal portion) was performed in each patients. Coronary abnormality is considered at the presence of any one of the following: 1) dilatation or aneurysm formation 2) lack of tapering 3) irregularity 4) intimal thickening(brightness) Results: Various coronary artery abnormalities were present in Kawasaki disease, include dilatation in 11(31%) patients, aneurysm formation in 2(6%) patients, lack of tapering in 13(37%) patients, irregularity in 12(34%) , and intimal thickening(brightness) in 23(65%) patients. Overall, coronary artery anomalies was present in 32(91%) of our patients in acute phase of disease. Conclusion: Our result showed that the incidence of coronary artery abnormalities in Kawasaki disease is higher than previously reported. Echocardiography can provide an accurate and timely diagnosis regarding the presence of cardiac and coronary artery lesions in Kawasaki diseases. With our SFCEI method, more detailed and comprehensive features of coronary artery abnormalities other than coronary aneurysm and dilatation can be provided.
ACETYLSALICYLIC ACID IN SODIUM CITRATE SOLUTION
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Commentaire du travail de Künzli HT et al., pp. 592
Authors: Julien Branche, Maxime Palazzo, Marine Camus, Gabriel Rahmi, Gilles Lesur
Journal: Endoscopy (2015)

See also: Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrett’s esophagusEndoscopy 2015; 47(07): 592-597DOI: 10.1055/s-0034-1391436
Biosynthesis of thromboxane A2 in renovascular hypertension
Authors: G. A. FitzGerald
Journal: JAMA (1984)

A variety of biologically active mediators are formed from arachidonic acid within the kidney. The most abundant metabolites are prostaglandins and thromboxane A<sub>2</sub>, formed via cyclic endoperoxide intermediates by the enzyme cyclooxygenase. These products are formed in response to phasic stimuli. They are not stored following synthesis, and their evanescent nature suggests that they are most likely to act locally as regulators of cellular homeostasis. Degradation products and metabolites of prostaglandins are generally biologically inactive. An exception is 6-keto-PGE<sub>1</sub>, a long-lived metabolite of prostacyclin formed by the enzyme 9α-hydroxy-prostaglandin-dehydrogenase. 6-Keto-PGE<sub>1</sub>, like prostacyclin, inhibits platelet aggregation, relaxes vascular smooth muscle, and is a potent renin secretagogue. However, although the kidney possesses the enzymatic machinery to generate 6-keto-PGE<sub>1</sub>, structural evidence that it is actually formed in vivo is still outstanding. In several species, the predominant cyclooxygenase product formed within the renal cortex is prostacyclin, virtually the exclusive metabolite
PEDACIUS DIOSCORIDES
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE ESSENTIAL PRINCIPLES OF INFANT FEEDING AND THE MODERN METHODS OF APPLYING THEM.
Authors: THOMAS MORGAN ROTCH
Journal: JAMA (1903)

The question of infant feeding is a very broad one; too broad, in fact, to be covered in one evening, or in one address. Although we usually consider that human beings are infants during the first two years of life, yet, so far as their feeding is concerned, it is the first twelve months of their existence in which the greatest difficulties arise in the proper adaptation of their food to their individual digestion, and to the requirements of their individual nutrition. An address on infant feeding, therefore, should naturally be devoted to the feeding of the first twelve months of life. It has for many years been an accepted fact the world over that the mortality of infants who are fed on good human milk, obtained from their mothers or other healthy women, is lower than that achieved by any other method of feeding. It should, however, at once
Commencement Exercises of the Chicago Medical College, Medical Department of the Northwestern University.
Authors: None S. M.
Journal: JAMA (1889)

<h3>Mr. Editor:</h3> —While attending the Thirtieth Annual Commencement Exercises of the above-named college, on the 26th of March, 1889, I noted the following items that will be of more or less interest to your readers in all parts of the country. The college was organized on the basis of a strictly graded system of medical education, and requires a fair standard of preliminary education for admission, three full years of medical study, including three annual courses of medical college instruction of not less than six months each, with laboratory and hospital clinical attendance two college courses. During the college year just closed the classes in attendance numbered as follows: 1st year class 79; 2d year class 52; 3d year class 51; making a total of 182. After music, and the opening prayer by Rev. Joseph Cummings, D.D., L.L.D., President of the University, the Dean of the medical faculty announced the
An X-Ray Atlas of the Normal and Abnormal Structures of the Body.
Journal: JAMA (1925)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Serial tuberculin testing and isoniazid therapy in general hospital employees
Authors: N. O. Atuk
Journal: JAMA (1971)

A tuberculin testing program for hospital employees was conducted at the University of Virginia Hospital over a two-year period. The rate of positive reactions was 13.6% among 1,980 employees tested in 1968 and 16.0% among 1,013 employees evaluated in 1969. The yearly conversion rate was 1.9%. Most of the converters were detected during follow-up of employees in contact with patients with active disease. Minimal, active pulmonary tuberculosis was observed on x-ray films of the chest in two converters. After one year of isoniazid treatment, 50% of the newly tuberculin converted employees reverted to negative, 25% had a decreased reaction, and 25% remained unchanged. The results reported in this study strongly support the need for the continuation of tuberculosis control programs in general hospitals.